Early research (Phase 1)Study completedNCT02670187What this trial is testingPhase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy VolunteersWho this might be right forHealthy GeneOne Life Science, Inc. 75
Not applicableStudy completedNCT02497885What this trial is testingSeroprevalence of MERS-CoV IgG in Healthcare WorkersWho this might be right forCoronavirus Infections Ewha Womans University Mokdong Hospital 737
Large-scale testing (Phase 3)Study completedNCT02845843What this trial is testingMERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1bWho this might be right forMiddle East Respiratory Syndrome Coronavirus (MERS-CoV) King Abdullah International Medical Research Center 95
Early research (Phase 1)WithdrawnNCT05614245What this trial is testingSafety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 AdjuvantWho this might be right forCOVID-19Coronavirus Infections VBI Vaccines Inc.
Early research (Phase 1)Study completedNCT03615911What this trial is testingSafety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-SWho this might be right forMERS (Middle East Respiratory Syndrome) Marylyn Addo 26
Testing effectiveness (Phase 2)Study completedNCT06857318What this trial is testingColostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.Who this might be right forCOVID 19 Hadassah Medical Organization 43
Not applicableStudy completedNCT01056185What this trial is testingRespiratory Virus Hospitalization Study (FLU 003 Plus)Who this might be right forInfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) University of Minnesota 1,000
Early research (Phase 1)Ended earlyNCT03399578What this trial is testingSafety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)Who this might be right forMERS (Middle East Respiratory Syndrome) University of Oxford 29
Early research (Phase 1)Study completedNCT04170829What this trial is testingA Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)Who this might be right forMiddle East Respiratory Syndrome Coronavirus King Abdullah International Medical Research Center 24
Not applicableStudy completedNCT01056354What this trial is testingRespiratory Virus Outpatient Study (FLU 002 Plus)Who this might be right forInfluenza and Other Novel Respiratory Viruses University of Minnesota 11,719
Testing effectiveness (Phase 2)Study completedNCT03721718What this trial is testingEvaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy VolunteersWho this might be right forHealthy GeneOne Life Science, Inc. 60
Early research (Phase 1)Study completedNCT04119440What this trial is testingSafety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERSWho this might be right forMERS (Middle East Respiratory Syndrome) Universitätsklinikum Hamburg-Eppendorf 145
Early research (Phase 1)UnknownNCT05548439What this trial is testingSafety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901aWho this might be right forCOVID-19Coronavirus Infections VBI Vaccines Inc. 103
Early research (Phase 1)Study completedNCT03301090What this trial is testingA Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051Who this might be right forCorona Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT02788188What this trial is testingSafety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy AdultsWho this might be right forMiddle East Respiratory Syndrome Coronavirus National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)Study completedNCT04588428What this trial is testingSafety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy VolunteersWho this might be right forMiddle East Respiratory Syndrome Coronavirus (MERS-CoV) Inovio Pharmaceuticals 192
Not applicableStudy completedNCT02605109What this trial is testingAnalysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)Who this might be right forViral Infection Konkuk University Medical Center 200
Testing effectiveness (Phase 2)WithdrawnNCT02190799What this trial is testingAnti-MERS-CoV Convalescent Plasma TherapyWho this might be right forRespiratory Distress Syndrome (& [Hyaline Membrane Disease]) King Abdullah International Medical Research Center
Early research (Phase 1)Study completedNCT02627378What this trial is testingSaudi Outcomes of ECMO-treated MERS-CoV PatientsWho this might be right forMERS-CoV InfectionRefractory Hypoxemia Imam Abdulrahman Bin Faisal University 35
Testing effectiveness (Phase 2)UnknownNCT04412395What this trial is testingClinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 DiseaseWho this might be right forCorona Virus InfectionMiddle East Respiratory Syndrome (MERS)Acute Respiratory Distress Syndrome+3 more National Research Centre, Egypt 516